Posted by Michael Wonder on 14 Nov 2015
FDA approves new pill to treat certain patients with non-small cell lung cancer
13 November 2015 - Today, the U.S. FDA granted accelerated approval for Tagrisso (osimertinib) for patients whose tumors have a specific epidermal growth factor receptor (EGFR) mutation (T790M) and whose disease has gotten worse after treatment with other EGFR-blocking therapy.
For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472525.htm
